Brief: Microba Life Sciences Says Q2 FY26 Total Revenue A$3.7M
29/01/2026 01:19
Jan 29 (Reuters) - Microba Life Sciences MAP.AX: Q2 FY26 TOTAL REVENUE A$3.7M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million